UnknownNot Applicable

Regional Midazolam in Quadratus Lumborum Block

Egypt60 participantsStarted 2022-03-15

Plain-language summary

Midazolam has been used in regional anesthesia of brachial plexus block; it has offered accepted postoperative pain relief. This study will use it in as an adjuvant to bupivacaine 0.25% in quadratus lumborum block in caesarean section

Who can participate

Age range24 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * American Society of Anesthesiologists (ASA) physical status I or II * age from 24 to 40 years old * weight from 50 to 80 kg, * normal singleton pregnancy with a gestation of at least 37 weeks Exclusion Criteria: * Coagulopathy * maternal anatomic abnormalities in the block region * localized infection * incapable of comprehending or using the verbal rating pain scoring system * Included medications allergy * history of chronic pain or regular opioid use.

What they're measuring

rescue analgesia

Timeframe: 24 hours

Trial details

NCT IDNCT05261672

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-31

Contact for this trial

Emad Z Kamel, MD

+201007046058 emadzarief@aun.edu.eg

View on ClinicalTrials.gov More Postoperative Pain trials